- No file added yet -

Cost-Effectiveness of Atezolizumab plus chemotherapy as first-line therapy for metastatic urothelial cancer

media

posted on 2021-05-17, 16:21 authored by Adis Rapid Journals on behalf of:, Shuxia Qin, Lidan Yi, Sini Li, Chongqing Tan, Xiaohui Zeng, Liting Wang, Ye Peng, Xiaomin Wan

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).